ERBB2 and breast cancer: In a retrospective study by Ryu et al., there were 647 cases of cT1-3 and cN0 breast cancer with HR-postive/HER2-negative subtype, of which 96 cases with breast pCR were confirmed to have no ALN metastasis, which is consistent with our findings [38].